Cost consideration in the clinical guidance documents of physician specialty societies in the United States
- PMID: 23649494
- DOI: 10.1001/jamainternmed.2013.817
Cost consideration in the clinical guidance documents of physician specialty societies in the United States
Abstract
Importance: Despite increasing concerns regarding the cost of health care, the consideration of costs in the development of clinical guidance documents by physician specialty societies has received little analysis.
Objective: To evaluate the approach to consideration of cost in publicly available clinical guidance documents and methodological statements produced between 2008 and 2012 by the 30 largest US physician specialty societies.
Design: Qualitative document review.
Main outcomes and measures: Whether costs are considered in clinical guidance development, mechanism of cost consideration, and the way that cost issues were used in support of specific clinical practice recommendations.
Results: Methodological statements for clinical guidance documents indicated that 17 of 30 physician societies (57%) explicitly integrated costs, 4 (13%) implicitly considered costs, 3 (10%) intentionally excluded costs, and 6 (20%) made no mention. Of the 17 societies that explicitly integrated costs, 9 (53%) consistently used a formal system in which the strength of recommendation was influenced in part by costs, whereas 8 (47%) were inconsistent in their approach or failed to mention the exact mechanism for considering costs. Among the 138 specific recommendations in these guidance documents that included cost as part of the rationale, the most common form of recommendation (50 [36%]) encouraged the use of a specific medical service because of equal effectiveness and lower cost.
Conclusions and relevance: Slightly more than half of the largest US physician societies explicitly consider costs in developing their clinical guidance documents; among these, approximately half use an explicit mechanism for integrating costs into the strength of recommendations. Many societies remain vague in their approach. Physician specialty societies should demonstrate greater transparency and rigor in their approach to cost consideration in documents meant to influence care decisions.
Comment in
-
Physician specialty society clinical guidelines and bending the cost curve: comment on "Cost consideration in the clinical guidance documents of physician specialty societies in the United States".JAMA Intern Med. 2013 Jun 24;173(12):1097-9. doi: 10.1001/jamainternmed.2013.820. JAMA Intern Med. 2013. PMID: 23649524 No abstract available.
Similar articles
-
Physician specialty society clinical guidelines and bending the cost curve: comment on "Cost consideration in the clinical guidance documents of physician specialty societies in the United States".JAMA Intern Med. 2013 Jun 24;173(12):1097-9. doi: 10.1001/jamainternmed.2013.820. JAMA Intern Med. 2013. PMID: 23649524 No abstract available.
-
American Society of Clinical Oncology guidance statement: the cost of cancer care.J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6. J Clin Oncol. 2009. PMID: 19581533
-
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.Value Health. 2013 Mar-Apr;16(2):231-50. doi: 10.1016/j.jval.2013.02.002. Value Health. 2013. PMID: 23538175
-
ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.Circulation. 2011 Sep 27;124(13):1483-502. doi: 10.1161/CIR.0b013e31822935fc. Epub 2011 Aug 29. Circulation. 2011. PMID: 21875906
-
Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.Pain Physician. 2008 Mar-Apr;11(2):161-86. Pain Physician. 2008. PMID: 18354710 Review.
Cited by
-
Cost-effectiveness of a second opinion program on spine surgeries: an economic analysis.BMC Health Serv Res. 2023 Dec 19;23(1):1441. doi: 10.1186/s12913-023-10405-x. BMC Health Serv Res. 2023. PMID: 38115007 Free PMC article.
-
Time to publication of cost-effectiveness analyses for medical devices.Am J Manag Care. 2023 May;29(5):265-268. doi: 10.37765/ajmc.2023.89359. Am J Manag Care. 2023. PMID: 37229785 Free PMC article.
-
Economic effect between surgery and thermal ablation for patients with papillary thyroid microcarcinoma: a systemic review and meta-analysis.Endocrine. 2022 Apr;76(1):9-17. doi: 10.1007/s12020-022-02991-3. Epub 2022 Feb 5. Endocrine. 2022. PMID: 35122627 Free PMC article.
-
Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.JAMA Intern Med. 2022 Feb 1;182(2):185-195. doi: 10.1001/jamainternmed.2021.7457. JAMA Intern Med. 2022. PMID: 34982097 Free PMC article.
-
Prevalence of Financial Considerations Documented in Primary Care Encounters as Identified by Natural Language Processing Methods.JAMA Netw Open. 2019 Aug 2;2(8):e1910399. doi: 10.1001/jamanetworkopen.2019.10399. JAMA Netw Open. 2019. PMID: 31469397 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
